Oncogenes meet metabolism : from deregulated genes to a broader understanding of tumour physiology /

Saved in:
Bibliographic Details
Imprint:Berlin ; New York : Springer, c2008.
Description:1 online resource (xv, 264 p.) : ill.
Language:English
Series:Ernst Schering Foundation symposium proceedings, 0947-6075 ; 2007-4
Ernst Schering Foundation Symposium Proceedings ; 2007/4.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8887308
Hidden Bibliographic Details
Other authors / contributors:Kroemer, Guido.
ISBN:9783540794776 (hbk. : alk. paper)
3540794778 (hbk. : alk. paper)
9783540794783 (electronic bk.)
3540794786 (electronic bk.)
9786611862497
6611862498
Notes:Includes bibliographical references.
Summary:In 1920s, Otto Warburg described the phenomenon of a aerobic glycolysisa (TM), the ability of tumour cells to convert glucose to lactate in the presence of normal oxygen conditions. Warburga (TM)s hypothesis of an altered metabolism in cancer cells found no immediate acceptance, though it was latter confirmed for most human tumours. With the advent of molecular biology the focus in tumour research has shifted towards the search for oncogenes. However, the interest in cancer molecular profiling eventually led to a renaissance of the Warburg effect trying to combine genetic alterations with effe.
Other form:Print version: Oncogenes meet metabolism. Berlin ; New York : Springer, c2008 9783540794776 3540794778

MARC

LEADER 00000cam a22000004a 4500
001 8887308
003 ICU
005 20120828155900.0
006 m d
007 cr |n|
008 080325s2008 gw a ob 000 0 eng c
016 7 |a 101485822  |2 DNLM 
016 7 |a 014675366  |2 Uk 
019 |a 272306764  |a 402415743  |a 607353303  |a 607553517  |a 646043891  |a 746945408 
020 |a 9783540794776 (hbk. : alk. paper) 
020 |a 3540794778 (hbk. : alk. paper) 
020 |a 9783540794783 (electronic bk.) 
020 |a 3540794786 (electronic bk.) 
020 |a 9786611862497 
020 |a 6611862498 
035 |a (OCoLC)302054329  |z (OCoLC)272306764  |z (OCoLC)402415743  |z (OCoLC)607353303  |z (OCoLC)607553517  |z (OCoLC)646043891  |z (OCoLC)746945408 
037 |a 186249  |b MIL 
040 |a COO  |b eng  |c COO  |d N$T  |d CEF  |d UBF  |d OCLCQ  |d UBC  |d UAB  |d E7B  |d OCLCQ  |d GW5XE  |d HNK  |d IDEBK  |d MHW  |d IAD  |d ISOBC 
042 |a pcc 
049 |a CGUA 
060 4 |a W1  |b ER715 no.4 2007 
060 4 |a QZ 202  |b O5478 2008 
072 7 |a HEA  |x 039030  |2 bisacsh 
082 0 4 |a 362.196/994  |2 22 
090 |a RC268.42  |b O55 2008 
245 0 0 |a Oncogenes meet metabolism :  |b from deregulated genes to a broader understanding of tumour physiology /  |c G. Kroemer ... [et al.], editors. 
260 |a Berlin ;  |a New York :  |b Springer,  |c c2008. 
300 |a 1 online resource (xv, 264 p.) :  |b ill. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
490 1 |a Ernst Schering Foundation symposium proceedings,  |x 0947-6075 ;  |v 2007-4 
504 |a Includes bibliographical references. 
505 0 |a Mitochondria and Cancer; Role of the Metabolic Stress Responses of Apoptosis and Autophagy in Tumor Suppression; The Interplay Between MYC and HIF in the Warburg Effect; Using Metabolomics to Monitor Anticancer Drugs; Biomarker Discovery for Drug Development and Translational Medicine Using Metabonomics; Pyruvate Kinase Type M2: A Key Regulator Within the Tumour Metabolome and a Tool for Metabolic Profiling of Tumours; Molecular Imaging of Tumor Metabolism and Apoptosis; Minimally Invasive Biomarkers for Therapy Monitoring; Use of Metabolic Pathway Flux Information in Anticancer Drug Design. 
520 |a In 1920s, Otto Warburg described the phenomenon of a aerobic glycolysisa (TM), the ability of tumour cells to convert glucose to lactate in the presence of normal oxygen conditions. Warburga (TM)s hypothesis of an altered metabolism in cancer cells found no immediate acceptance, though it was latter confirmed for most human tumours. With the advent of molecular biology the focus in tumour research has shifted towards the search for oncogenes. However, the interest in cancer molecular profiling eventually led to a renaissance of the Warburg effect trying to combine genetic alterations with effe. 
650 0 |a Oncogenes.  |0 http://id.loc.gov/authorities/subjects/sh85094721 
650 0 |a Cancer  |x Pathophysiology.  |0 http://id.loc.gov/authorities/subjects/sh87005720 
650 0 |a Cell metabolism.  |0 http://id.loc.gov/authorities/subjects/sh85021656 
650 1 2 |a Oncogenes. 
650 2 2 |a Neoplasms  |x genetics. 
650 2 2 |a Neoplasms  |x metabolism. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
655 4 |a Electronic books. 
650 7 |a Cancer  |x Pathophysiology.  |2 fast  |0 http://id.worldcat.org/fast/fst00845410 
650 7 |a Cell metabolism.  |2 fast  |0 http://id.worldcat.org/fast/fst00850203 
650 7 |a Oncogenes.  |2 fast  |0 http://id.worldcat.org/fast/fst01045729 
700 1 |a Kroemer, Guido.  |0 http://id.loc.gov/authorities/names/n94801434  |1 http://viaf.org/viaf/92175128 
776 0 8 |i Print version:  |t Oncogenes meet metabolism.  |d Berlin ; New York : Springer, c2008  |z 9783540794776  |z 3540794778  |w (DLC) 2008925641  |w (OCoLC)293319991 
830 0 |a Ernst Schering Foundation Symposium Proceedings ;  |v 2007/4. 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-79478-3  |y SpringerLink 
903 |a HeVa 
035 |a (ICU)8887308 
929 |a eresource 
999 f f |i 5b9d1e58-c86d-5461-9e41-2b7cd9af0315  |s c662efb2-4673-5544-be82-4e7353e8cee3 
928 |t Library of Congress classification  |a RC268.42 O55 2008  |l Online  |c UC-FullText  |u http://dx.doi.org/10.1007/978-3-540-79478-3  |z SpringerLink  |g ebooks  |i 11466148